ÂÜÀòÂÒÂ×

Feyi Ayodele is the Founder and Chief Executive Officer of Cancer IQ, Inc., a healthcare technology venture established to utilize genetic information in disease prediction and prevention, particularly for cancer. Since founding the company in June 2013, Feyi has successfully raised over $26 million in venture capital, launched a commercial product, expanded the user base to over 225 hospitals, and formed strategic partnerships to enhance growth. Feyi's accomplishments include multiple awards such as the Chicago Innovation Award and recognition in Crain Chicago Business's 40 Under 40. Feyi also serves as a Fellow at Rock Health and has held various roles in project management and investment analysis, including as a summer associate at McKinsey & Company and Actis, and as Managing Director of the Wharton Social Venture Fund. Feyi holds an MBA in Private Equity and Venture Capital from The Wharton School and a BSc in Finance and Management from the same institution.